Author

Mark Lowenberg 1

1 Department Of Gastroenterology And Hepatology, Amc Amsterdam, Amsterdam, Netherlands

ANTI-TNF USE IS ASSOCIATED WITH WORK PRODUCTIVITY LOSS IN IBD PATIENTS

Sara van Gennep, Sanne W. Evers, Angela G.E.M. de Boer, Nanne K. de Boer, Svend T. Rietdijk, Marieke E. Gielen, Krisztina Barbara Gecse, Cyriel Y. Ponsioen, J.K. Sluiter, Geert R. D'Haens, Mark Lowenberg

ARE HIGH INFLIXIMAB TROUGH LEVELS ASSOCIATED WITH IMPAIRED QUALITY OF LIFE IN IBD PATIENTS IN CLINICAL AND BIOCHEMICAL REMISSION ON INFLIXIMAB MAINTENANCE THERAPY?

Mark Lowenberg, Laura Vos, Cyriel Y. Ponsioen, Gijs R. van den Brink, Geert R. D'Haens

ASSESSMENT OF THE PERFORMANCE OF THE COLONIC PILLCAM PCCE-2 IN PATIENTS WITH ACTIVE COLONIC CROHN'S DISEASE: A PILOT STUDY

Mark Lowenberg, Mark A Samaan, Denis Franchimont, Cyriel Y. Ponsioen, Leila Amininejad, Elsemieke Lensink, André Van Gossum, Geert R. D'Haens

association between serum and tissue protein profiles in patients with inflammatory bowel disease: the ascertain study

Toer W. Stevens, Matic Koželj, Gregor Novak, Krisztina Barbara Gecse, Marjolijn Duijvestein, Mark Lowenberg, Manon E. Wildenberg, David Drobne, Geert R. D'Haens

BASELINE HYPERTROPHY OF THE SUBMUCOSA AT INTESTINAL ULTRASOUND PREDICTS FAILURE OF TREATMENT IN PATIENTS WITH ULCERATIVE COLITIS

Floris de Voogd, Cyriel Y. Ponsioen, Marjolijn Duijvestein, Mark Lowenberg, Krisztina Barbara Gecse, Geert R. D'Haens

Case presentation

Mark Lowenberg

Case presentation

Mark Lowenberg

CLINICAL AND ENDOSCOPIC RESPONSE TO TREAT-TO-TARGET VERSUS STANDARD OF CARE IN CROHN'S DISEASE PATIENTS TREATED WITH USTEKINUMAB: WEEK 48 RESULTS OF THE STARDUST TRIAL

Silvio Danese, Severine Vermeire, Geert R. D'Haens, Julian Panés, Axel Dignass, Fernando Jose Magro Dias, Maciek Nazar, Manuela Le Bars, Marjolein Lahaye, Lioudmila Ni, Fréderic Lavie, Ivana Bravata, Sheldon Sloan, Marco Daperno, Milan Lukas, Alessandro Armuzzi, Mark Lowenberg, Daniel R. Gaya, Laurent Peyrin-Biroulet

COMBINED ENDOSCOPIC AND HISTOLOGICAL HEALING WITH VEDOLIZUMAB IN THERAPY-REFRACTORY CROHN'S DISEASE, DATA FROM THE LOVE-CD TRIAL

Mark Lowenberg

Combined endoscopic and histological healing with vedolizumab in therapy-refractory Crohn's disease, data from the LOVE-CD trial

Mark Lowenberg, Nahid Mostafavi, Severine Vermeire, Frank Hoentjen, C. Ambarus, Esmé Clasquin, Filip Baert, Geert R. D'Haens

Item 1 - 10 / 35
1
2 3 4